Literature DB >> 5812457

Combined hormone control therapy and radical prostatectomy in the treatment of selected cases of advanced carcinoma of the prostate: a retrospective study based upon 25 years of experience.

W W Scott, H L Boyd.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1969        PMID： 5812457     DOI： 10.1016/s0022-5347(17)62280-8

Source DB:  PubMed          Journal:  J Urol        ISSN： 0022-5347            Impact factor:   7.450


× No keyword cloud information.
  6 in total

Review 1.  Current concepts in the management of carcinoma of the prostate gland.

Authors:  E M Meares
Journal:  Calif Med       Date:  1972-12

2.  Estracyt in hormone-resistant prostatic carcinoma.

Authors:  Z Szendröi; I Könyves; L Szendi; S Eckhardt; F Hartay
Journal:  Int Urol Nephrol       Date:  1974       Impact factor: 2.370

3.  Long-term follow-up of 3-month neoadjuvant hormone therapy before radical prostatectomy in a randomized trial.

Authors:  David S Yee; William T Lowrance; James A Eastham; Alexandra C Maschino; Angel M Cronin; Farhang Rabbani
Journal:  BJU Int       Date:  2009-07-08       Impact factor: 5.588

4.  Sexual functioning morbidity among cancer survivors. Current status and future research directions.

Authors:  B L Andersen
Journal:  Cancer       Date:  1985-04-15       Impact factor: 6.860

5.  Significance of androgen deprivation prior to radical prostatectomy, with special reference to prostate-specific antigen.

Authors:  M S Soloway; T Hachiya; H E Ruiz; C C Gomez; F Civantos
Journal:  World J Urol       Date:  1993       Impact factor: 4.226

Review 6.  Erectile impotence: a clinical challenge.

Authors:  J B McKendry; W E Collins; M Silverman; L E Krul; J P Collins; A H Irvine
Journal:  Can Med Assoc J       Date:  1983-03-15       Impact factor: 8.262
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.